- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - J3590
  conditions:
    all_of:
    - dx_in_value_set: vs_hepatitis_c_chronic_2025_09
    - has_flag: hcv_rna_detectable
    - has_flag: genotype_testing_completed
    none_of:
    - has_flag: active_substance_abuse_untreated
    - dx_in_value_set: vs_decompensated_liver_disease_2025_09
    - has_flag: drug_drug_interactions_significant
  logic:
    outcome: PA_REQUIRED
    notes: Hepatitis C DAA therapy requires detectable HCV RNA, genotype testing,
      and absence of contraindications
  precedence: 95
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_hepatitis_treatment_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_d6e5748af137
- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - J3590
  conditions:
    any_of:
    - all_of:
      - dx_in_value_set: vs_hepatitis_b_chronic_2025_09
      - has_flag: hbv_dna_elevated
      - has_flag: alt_elevated
    - all_of:
      - dx_in_value_set: vs_hepatitis_b_chronic_2025_09
      - dx_in_value_set: vs_cirrhosis_2025_09
    - dx_in_value_set: vs_hepatitis_b_reactivation_risk_2025_09
    none_of:
    - has_flag: renal_impairment_severe
    - has_flag: bone_disease_significant
  logic:
    outcome: PA_REQUIRED
    notes: Hepatitis B antiviral therapy for elevated HBV DNA/ALT, cirrhosis, or reactivation
      risk
  precedence: 90
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_hepatitis_treatment_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_5d8dc0d00ed2
- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - '87520'
    - '87521'
    - '87522'
  conditions:
    any_of:
    - all_of:
      - dx_in_value_set: vs_hepatitis_c_chronic_2025_09
      - has_flag: treatment_monitoring_phase
    - all_of:
      - dx_in_value_set: vs_hepatitis_c_acute_2025_09
      - has_flag: spontaneous_clearance_assessment
    - has_flag: hcv_treatment_response_evaluation
    none_of:
    - has_flag: hcv_rna_testing_within_4_weeks
  logic:
    outcome: PA_REQUIRED
    notes: HCV RNA monitoring during treatment, acute infection assessment, or response
      evaluation
  precedence: 85
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_hepatitis_treatment_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_f6922f4762f8
- type: PRIOR_AUTH
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - '87340'
    - '87341'
  conditions:
    any_of:
    - all_of:
      - dx_in_value_set: vs_hepatitis_b_chronic_2025_09
      - has_flag: antiviral_therapy_monitoring
    - all_of:
      - dx_in_value_set: vs_hepatitis_b_inactive_carrier_2025_09
      - has_flag: surveillance_monitoring
    - dx_in_value_set: vs_hepatitis_b_reactivation_risk_2025_09
    none_of:
    - has_flag: hbv_dna_testing_within_3_months
  logic:
    outcome: PA_REQUIRED
    notes: HBV DNA monitoring for treatment response, inactive carrier surveillance,
      or reactivation risk
  precedence: 85
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_hepatitis_treatment_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_d1a7b7a78c90
- type: EDIT
  scope:
    carrier_id: crr_7f9b2e1a2b3c
    lob: commercial_fully_insured
    state: CA
    plan_type: ''
    market: ''
  service_ref:
    cpt:
    - J3590
  conditions:
    all_of:
    - dx_in_value_set: vs_hepatitis_c_chronic_2025_09
    - has_flag: treatment_experienced_failure
    none_of:
    - has_flag: resistance_testing_completed
    - has_flag: specialist_consultation
  logic:
    outcome: DENY
    notes: HCV treatment failure requires resistance testing and specialist consultation
      before retreatment
  precedence: 95
  effective_start: '2025-01-01'
  effective_end: '2025-12-31'
  _meta:
    source: sources/2025-09/unitedhealth/uhc_hepatitis_treatment_2025.pdf
    last_verified_at: '2025-09-11'
  id: rule_c4fe48a4ece1
